Testing Doxazosin to Treat Stress Mechanisms in Alcoholism
Status:
Completed
Trial end date:
2020-03-13
Target enrollment:
Participant gender:
Summary
Double-blind, placebo controlled, randomized controlled trial (RCT) for Alcohol Use Disorder
examining the effects of doxazosin, a norepinephrine alpha1 receptor antagonist, on stress
reactivity and clinical outcomes.
Phase:
Phase 2
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)